Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Online ISSN : 1882-4528
Print ISSN : 0030-1558
Volume 124, Issue 1
Displaying 1-16 of 16 articles from this issue
The 2010 Okayama Medical Association Awards
Reviews
Original Paper
  • Hideaki Miyasou, Kazuhide Iwakawa, Masaru Inagaki, Yuuji Kimura, Manab ...
    2012 Volume 124 Issue 1 Pages 47-51
    Published: April 02, 2012
    Released on J-STAGE: April 29, 2012
    JOURNAL RESTRICTED ACCESS
    This study was aimed to clarify the prognostic factors in colorectal cancer patients with synchronous liver metastasis. Fifty-four patients were assessed to evaluate prognoses according to various clinico-pathological factors and therapeutic procedures. The patients' survival was significantly related to extrahepatic distant metastasis and therapeutic procedures. Regarding therapeutic procedures, the liver resection group showed significantly improved survival compared with the chemotherapy group, especially in liver metastasis Grade B. For colorectal liver metastases, it is clear that liver resection is the most effective treatment at present. Further improvement of patient prognoses is expected to be achieved by future research on combination chemotherapy.
    Download PDF (489K)
Case Reports
  • Ryosuke Hamano, Masaru Inagaki, Yuuji Kimura, Kenta Isoda, Koji Kitada ...
    2012 Volume 124 Issue 1 Pages 53-57
    Published: April 02, 2012
    Released on J-STAGE: April 29, 2012
    JOURNAL RESTRICTED ACCESS
    A 35-year-old man was found to have a cystic mass in the pancreatic body on a routine health examination ; high serum CA19-9 was also detected. The enucleated cyst was diagnosed as a lymphoepithelial cyst (LEC). A 74-year-old man found to have a cystic mass in the pancreatic head by computer tomography as well as high serum CA19-9 was suspected of a cystic neoplasm of the pancreas (IPMN), and pylorus-preserving pancreaticoduodenectomy (PPPD) was performed. Pathologically, the cyst was found to be LEC. It is often difficult to diagnose pancreatic cyst as LEC preoperatively. Care should be taken not to do over-surgery for benign disease LEC.
    Download PDF (3539K)
  • Susumu Shinoura, Takahito Yagi, Hiroshi Sadamori, Hiroaki Matsuda, Yuz ...
    2012 Volume 124 Issue 1 Pages 59-62
    Published: April 02, 2012
    Released on J-STAGE: April 29, 2012
    JOURNAL RESTRICTED ACCESS
    We experienced a case of gastric aberrant pancreas with acute pancreatitis. The patient was a 42-year-old man. He was referred to our hospital because of epigastric pain. A CT scan and endoscopic examination revealed a gastric submucosal tumor with inflammation. His serum amylase level was high at 222 IU/l. Endoscopic ultrasonography revealed a hypoechoic mass lesion, 3 cm in diameter, at the body of his stomach. Endoscopic ultrasoundscopy-guided fine needle aspiration was performed. Pathological examination showed pancreatic tissue. So, he underwent partial gastrectomy due to gastric aberrant pancreas with pancreatitis. There are very few cases of gastric aberrant pancreas with pancreatitis on record.
    Download PDF (5339K)
  • Masahiko Nishizaki, Yasuhiro Fujiwara, Yasuhiro Chouda, Takashi Kanaza ...
    2012 Volume 124 Issue 1 Pages 63-66
    Published: April 02, 2012
    Released on J-STAGE: April 29, 2012
    JOURNAL RESTRICTED ACCESS
    A 59-year-old man with epigastric discomfort and anorexia was referred to our hospital. Endoscopy revealed a type 3 advanced gastric cancer with pyloric stenosis diagnosed as a poorly differentiated adenocarcinoma in the biopsy specimens. A gastrojejunal bypass operation was performed because of direct invasion to the pancreas. The patient was treated by three courses of neoadjuvant chemotherapy with S-1/CDDP. Follow-up abdominal CT scan revealed that the primary tumor had become smaller, suggesting that a partial response had been achieved. Distal gastrectomy with D2 lymphadenectomy was performed. The histopathological examination showed no residual cancer cells in the primary lesion or dissected lymph nodes. Final chemotherapy efficacy was evaluated as Grade 3. The patient was treated with S-1 for one year after the gastrectomy and lymphadenectomy and has been followed up for 18 months without evidence of recurrence.
    Download PDF (4987K)
Feature Article
Challenges to intractable diseases
Guidelines
Cardiovascular Medicine
Infectious Disease
News & View
Tips for Proper Drug Use
Key Word
feedback
Top